KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Feb 20, 2024 | Sale | $14.11 | 12,053 | 170,124 | 72,895 | Feb 21, 2024, 09:48 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Feb 14, 2024 | Sale | $15.01 | 39,886 | 598,661 | 66,160 | Feb 16, 2024, 04:18 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Nov 20, 2023 | Sale | $8.23 | 7,113 | 58,535 | 46,046 | Nov 21, 2023, 04:32 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Aug 18, 2023 | Sale | $10.73 | 7,142 | 76,624 | 41,662 | Aug 21, 2023, 08:06 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | May 18, 2023 | Sale | $10.14 | 2,604 | 26,416 | 37,310 | May 19, 2023, 09:20 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Feb 17, 2023 | Sale | $7.66 | 2,727 | 20,889 | 35,709 | Feb 23, 2023, 05:42 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Nov 18, 2022 | Sale | $5.44 | 1,139 | 6,196 | 34,232 | Nov 21, 2022, 04:21 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Aug 17, 2022 | Sale | $14.96 | 1,145 | 17,130 | 33,597 | Aug 19, 2022, 05:16 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Nov 01, 2021 | Sale | $18.07 | 5,000 | 90,328 | 32,969 | Nov 03, 2021, 04:56 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Aug 02, 2021 | Sale | $20.52 | 5,000 | 102,578 | 37,969 | Aug 04, 2021, 07:55 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Feb 23, 2021 | Sale | $33.59 | 15,000 | 503,877 | 62,169 | Feb 25, 2021, 08:25 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Oct 29, 2020 | Sale | $17.48 | 5,000 | 87,394 | 62,969 | Nov 02, 2020, 08:01 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Oct 20, 2020 | Sale | $17.49 | 7,942 | 138,886 | 76,315 | Oct 22, 2020, 05:36 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Oct 21, 2020 | Sale | $18.25 | 6,044 | 110,282 | 70,513 | Oct 22, 2020, 05:36 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Oct 16, 2020 | Sale | $17.00 | 914 | 15,539 | 81,955 | Oct 20, 2020, 02:14 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Feb 05, 2020 | Sale | $17.10 | 100 | 1,710 | 82,869 | Feb 07, 2020, 05:18 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Dec 20, 2019 | Option Exercise | $8.51 | 5,292 | 45,037 | 85,615 | Dec 26, 2019, 05:32 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Dec 12, 2019 | Sale | $8.50 | 398 | 3,384 | 83,168 | Dec 16, 2019, 07:34 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Dec 13, 2019 | Option Exercise | $8.52 | 3,000 | 25,574 | 84,469 | Dec 16, 2019, 07:34 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Dec 16, 2019 | Option Exercise | $8.53 | 6,020 | 51,331 | 85,979 | Dec 16, 2019, 07:34 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Jul 22, 2019 | Sale | $9.17 | 14,710 | 134,961 | 90,324 | Jul 24, 2019, 05:53 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Apr 22, 2019 | Sale | $13.02 | 14,710 | 191,561 | 90,324 | Apr 23, 2019, 05:33 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Jan 25, 2019 | Option Exercise | $8.53 | 10,906 | 93,039 | 88,422 | Jan 29, 2019, 06:53 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Jan 22, 2019 | Option Exercise | $8.50 | 2,604 | 22,145 | 84,271 | Jan 24, 2019, 07:48 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Jan 23, 2019 | Option Exercise | $8.51 | 1,200 | 10,208 | 83,569 | Jan 24, 2019, 07:48 PM |